About the author

doreilly081 Welcome to the Intelligent Medicine Blog.  We focus on how embedded computer and sensor technology is redefining and revolutionizing health care.  We explore and analyze implantable, wearable, digestible and carry-able computers that are rapidly becoming integrated into the pharmaceutical, medical device and wellness management products of the future.

This blog is written by David O’Reilly, a life sciences executive and entrepreneur focused on developing platform technologies that improve medical product development and health care delivery. David is Senior Vice President, Corporate Development of Proteus Biomedical. He is responsible for Proteus’s corporate development functions across its therapeutic medical device, pharmaceutical and hospital programs and leads the strategic development of the company’s Pharmaceutical Systems Division. Prior to Proteus, he was President of Catalyst Biosciences, a company developing novel therapeutic protein products based on engineered proteases. Prior to Catalyst, David was Chief Business Officer and part of the founding management team at Iconix Biosciences (now part of Entelos), a leading chemogenomics company, where he led all commercial functions at the company. Prior to Iconix, David was an executive at ARIAD Pharmaceuticals, Inc., where he was responsible for partnerships and licenses with pharmaceutical, biotechnology and academic organizations. He also managed the strategic development of ARIAD’s gene therapy subsidiary, ARIAD Gene Therapeutics, Inc. David began his career as a management consultant with L.E.K. Consulting, where he developed strategic and operational plans and advised on mergers and acquisitions for biotechnology, pharmaceutical and other life sciences organizations. David is a graduate of Wesleyan University and Harvard Business School.

Proteus  Biomedical, Inc.

Proteus ChipSkin enables the distribution of sensors and digital electronics in the body

Proteus ChipSkin enables the distribution of sensors and digital electronics in the body, making any implanted device a networked computer

Proteus ingestible microchips enable the networking of the daily pill and the connection of therapy to an individual's physiologic response

Proteus ingestible microchips enable the networking of the daily pill and the connection of therapy to an individual's physiologic response

Proteus Raisin System brings together networked pills, wearable physiologic monitoring, and mobile health for an integrated personalized medicine solution

Proteus Raisin System brings together networked pills, wearable physiologic monitoring, and mobile health for an integrated personalized medicine solution

  • IntelliMed on Twitter

    Error: Twitter did not respond. Please wait a few minutes and refresh this page.

  • Daily IntelliMed News

  • Recent Posts

  • Subscribe to IntelliMedBlog
  • Contact Us
  • Archives

  • Categories

  • View David O’Reilly's profile on LinkedIn
  • Proteus Named 2009 WEF Technology Pioneer
  • Pages